Our results showed that α-hederin treatment significantly inhibited colorectal tumor formation and growth by inhibiting p38 MAPK/STAT3 inflammatory-cancer transformation pathway and attenuating oxidative stress (Fig. 4). The gene discussed is STAT3; the disease is cancer.